GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Curis, Inc. (CRIS) [hlAlert]

Rating:
Outperform
CRIS
up 87.96 %

Curis, Inc. (CRIS) rated Outperform by RBC Capital Mkts

Posted on: Tuesday,  May 13, 2008  8:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Curis, Inc. (NASDAQ: CRIS) on 05/13/2008, when the stock price was $1.33. Since
then, Curis, Inc. has gained 87.97% as of 01/22/2016's recent price of $2.50.
If you would have followed this RBC Capital Mkts's recommendation on CRIS, you would have gained 87.96% of your investment in 2810 days.

Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2008 8:25 AM Buy
None
1.33
as of 12/24/2008
1 Week up  3.81 %
1 Month up  13.33 %
3 Months up  58.13 %
1 YTD up  81.33 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy